RIGL

RIGL

USD

Rigel Pharmaceuticals Inc. Common Stock

$28.380-1.710 (-5.683%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$30.090

Haut

$30.795

Bas

$28.080

Volume

0.31M

Fondamentaux de l'Entreprise

Capitalisation Boursière

509.1M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.71M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $13.91Actuel $28.380Haut $43.72

Actualités Connexes

PR Newswire

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...

Voir plus
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
CNBC

This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'

Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.

Voir plus
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'
PR Newswire

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on...

Voir plus
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.